EMERGINGDX INC — Department of Agriculture SBIR Phase I: 8.7

EMERGINGDX INC — SBIR Phase I award from Department of Agriculture.

Phase I SBIR feasibility signal

  • Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Agriculture in a technical approach.
  • Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
  • Obligated amount $181,246. Cross-check similar awards in the same agency and technology tags for going-rate context.
  • Topic code 8.7 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$181,246
Agency
Department of Agriculture
Program / Phase
SBIR · Phase I
Topic
8.7
Solicitation
USDA-NIFA-SBIR-009301
NAICS
Place of performance
MA
Period
2023-04-03 → 2024-02-29

Description

EmergingDx Inc. in collaboration with Michigan State University will leverage on-goingprograms and their collective expertise to develop a rapid low-cost multiplexed colorimetricquantitative loop-mediated isothermal amplification (qLAMP) microfluidic based diagnostic devicewith high sensitivity and selectivity for screening reproductive fluids/gametes to be used forbreaking the vertical transmission of pathogens in aquaculture.In Phase I period we will develop and demonstrate a paradigm shift concept for detection of fishpathogens. EmergingDx's proposed colorimetric microfluidic based diagnostic device involves (i)adapting MSU's existing LAMP assay capable of identifying Flavobacterium psychrophilum inovarian fluid and milt (ii) a self-contained robust rapid low-cost low power hand-held novelmicrofluidic device and (iii) colorimetric detection and data analytics with a phone app forquantification and data storage/transmission. At the end of the Phase I program we will deliver 1) adetailed feasibility study to demonstrate the scientific technical and commercial merit of ourdiagnostic platform; and 2) a technology transition plan.